ES2055339T3 - Composicion oftalmica liquido acuosa que presenta una fase de transicion liquido-gel. - Google Patents

Composicion oftalmica liquido acuosa que presenta una fase de transicion liquido-gel.

Info

Publication number
ES2055339T3
ES2055339T3 ES90311208T ES90311208T ES2055339T3 ES 2055339 T3 ES2055339 T3 ES 2055339T3 ES 90311208 T ES90311208 T ES 90311208T ES 90311208 T ES90311208 T ES 90311208T ES 2055339 T3 ES2055339 T3 ES 2055339T3
Authority
ES
Spain
Prior art keywords
liquid
ophthalmic composition
transition phase
gel transition
composition presenting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90311208T
Other languages
English (en)
Inventor
Gilles Chastaing
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratories Merck Sharp and Dohme Chibret SAS
Original Assignee
Laboratories Merck Sharp and Dohme Chibret SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratories Merck Sharp and Dohme Chibret SAS filed Critical Laboratories Merck Sharp and Dohme Chibret SAS
Application granted granted Critical
Publication of ES2055339T3 publication Critical patent/ES2055339T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION ES RELATIVA A UNA COMPOSICION OFTALMICA, CARACTERIZADA POR QUE COMPRENDE AL MENOS UN PRINCIPIO ACTIVO Y UN POLISACARIDO SULFATADO O DERIVADO DE POLISACARIDO SULFATADO EN SOLUCION ACUOSA, LA CUAL ESTA EN FASE DE TRANSICION LIQUIDO-GEL EN INTERACCION DE DICHO POLISACARIDO SULFATADO O UNO DE SUS DERIVADOS CON LAS PROTEINAS DEL FLUIDO LACRIMAL. LA PRESENTE INVENCION TAMBIEN ES RELATIVA A UN PROCESO PARA PREPARAR LA CITADA COMPOSICION.
ES90311208T 1989-10-17 1990-10-12 Composicion oftalmica liquido acuosa que presenta una fase de transicion liquido-gel. Expired - Lifetime ES2055339T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8913534A FR2653021A1 (fr) 1989-10-17 1989-10-17 Composition ophtalmique aqueuse liquide a transition de phase liquide-gel.

Publications (1)

Publication Number Publication Date
ES2055339T3 true ES2055339T3 (es) 1994-08-16

Family

ID=9386463

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90311208T Expired - Lifetime ES2055339T3 (es) 1989-10-17 1990-10-12 Composicion oftalmica liquido acuosa que presenta una fase de transicion liquido-gel.

Country Status (9)

Country Link
EP (1) EP0424043B1 (es)
JP (1) JP3043795B2 (es)
AT (1) ATE89745T1 (es)
CA (1) CA2027630C (es)
DE (1) DE69001739T2 (es)
DK (1) DK0424043T3 (es)
ES (1) ES2055339T3 (es)
FR (1) FR2653021A1 (es)
IE (1) IE64045B1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2594486B2 (ja) * 1991-01-15 1997-03-26 アルコン ラボラトリーズ インコーポレイテッド 局所的眼薬組成物
JP2536806B2 (ja) * 1991-03-27 1996-09-25 アルコン ラボラトリーズ インコーポレイテッド ゲル化多糖類と微粉砕された薬剤担体とを組み合わせた局部眼科用組成物
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
US6261547B1 (en) 1998-04-07 2001-07-17 Alcon Manufacturing, Ltd. Gelling ophthalmic compositions containing xanthan gum
US6174524B1 (en) 1999-03-26 2001-01-16 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
AU8008300A (en) 1999-11-01 2001-05-14 Alcon Inc. Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum
PT1305033E (pt) 2000-07-28 2005-01-31 Alcon Inc Composicoes farmaceuticas que contem tobramicina e goma de xantano
PE20020578A1 (es) 2000-10-10 2002-08-14 Upjohn Co Una composicion de antibiotico topico para el tratamiento de infecciones oculares
WO2002040056A2 (en) 2000-11-06 2002-05-23 Alcon, Inc Carrageenan viscoelastics for ocular surgery
CA2477044A1 (en) 2002-02-22 2003-09-04 Pharmacia Corporation Ophthalmic formulation with gum system
US20080131454A1 (en) * 2006-12-05 2008-06-05 Marinomed Biotechnologie Gmbh Methods and Compositions for the Treatment of Rhinovirus Infections with Carrageenan
WO2011018800A2 (en) 2009-08-13 2011-02-17 Fdc Limited A novel in-situ gel forming solution for ocular drug delivery
HUE044329T2 (hu) * 2014-01-22 2019-10-28 Visufarma B V Iota-karragént tartalmazó készítmény vírusos kötõhártya-gyulladás ellen
PT3370692T (pt) * 2015-07-14 2023-07-18 Marinomed Biotech Ag Composição que elimina a congestão nasal e possui atividade antiviral
CN109752557B (zh) * 2017-11-06 2021-06-08 清华大学 检测生物分子间相互作用及其调控因子的成套试剂与应用
DE202022102900U1 (de) 2022-05-25 2023-01-13 Anant Narayanrao Deshpande Tetrahydrocurcumin niosomales in-situ-Gel für okulare Arzneimittelabgabe

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136173A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
FR2542616B1 (fr) * 1983-03-17 1987-07-31 Unilever Nv Composition pour le traitement des muqueuses a base d'un antibiotique et d'un hydrocolloide formateur de gel
US4717713A (en) * 1983-10-31 1988-01-05 Research Corporation Controlled release liquid pharmaceutical
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
DE3601132A1 (de) * 1986-01-16 1987-07-23 Christian Bannert Verfahren zur behandlung der schleimhaut
GB2203039B (en) * 1987-03-02 1990-10-24 American Cyanamid Co Stable ophthalmic preparations containing acetazolamide

Also Published As

Publication number Publication date
IE903713A1 (en) 1991-04-24
IE64045B1 (en) 1995-06-28
DK0424043T3 (da) 1993-06-21
FR2653021A1 (fr) 1991-04-19
DE69001739D1 (de) 1993-07-01
DE69001739T2 (de) 1993-11-25
ATE89745T1 (de) 1993-06-15
EP0424043A1 (en) 1991-04-24
JP3043795B2 (ja) 2000-05-22
CA2027630C (en) 2001-04-24
JPH03133936A (ja) 1991-06-07
EP0424043B1 (en) 1993-05-26
CA2027630A1 (en) 1991-04-18

Similar Documents

Publication Publication Date Title
ES2055339T3 (es) Composicion oftalmica liquido acuosa que presenta una fase de transicion liquido-gel.
DE69019205D1 (de) Bohrlochbehandlungsflüssigkeit, enthaltend vernetzbare Zellulosederivate.
DK0527801T3 (da) Thiophensulfonamider, der er anvendelige som carboanhydraseinhibitorer
DE69001730D1 (de) Pastenfoermige, waesserige pharmazeutische zusammensetzungen.
NO902319L (no) Fremgangsmaate for aa bestemme egenskaper vedroerende stroemningsdynamikk for flerfasestroemning.
BR8901693A (pt) Composicao detergente liquida,nao caustica,de fase unica
BR9604878A (pt) Preparado oftálmico em gel gotejável estéril e processo para sua preparação
NO894963L (no) Flytende vaskemiddel, samt fremgangsmaate for dets fremstilling.
ES2098140T3 (es) Liosferas que contienen gonadotropina.
DK0909562T3 (da) Injektionspræparat indeholdende en lipid A analog og fremgangsmåde til fremstilling deraf
TR26910A (tr) Konsantre, sulu sivi deterjan bilesimleri.
PT91475A (pt) Processo para a preparacao de uma composicao detergente liquida de accao nao reforcada, contendo um sistema de agentes tensio-activos
NO900575D0 (no) Anordning ved flaske med medisinsk vaeske.
NO881617D0 (no) Vannloeselige additiver med ekstrem trykkvirkning for vandige funksjonsfluider, funksjonsfluider og konsentrerte vandige blandinger som inneholder de nevnte additiver.
KR970705985A (ko) 각막 장해 복구용 점안제(Eye Drops for Repairing Corneal Disturbance)
BR0110829A (pt) Composição detergente lìquida isotrópica concentrada fisicamente estável, e, processo para estabilizar protease em uma composição detergente lìquida isotrópica concentrada fisicamente estável
NO960364D0 (no) Basisk-substituerte benzolguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen
KR900007816A (ko) 사이클로프로필-치환된 아졸릴메틸카비놀, 이의 제조방법 및 약제로서의 이의 용도
FR2676445B1 (fr) Derives de pyridone amino acide azetidinyl substitues, leur preparation et leur application en tant que medicaments.
IT1227787B (it) Oxo isoindolinil derivati otticamente attivi.
NO903007D0 (no) 6- og 7-deoksyforskolin samt derivater derav, mellomprodukter og fremgangsmaate for fremstilling derav, samt anvendelse som medikamenter.
IT1215408B (it) Dispositivo per l'adduzione dosata di lega leggera liquida nel cilindro di pressione.
DK260884D0 (da) 7-oxo-4-thia-1-azabicyclo(3.2.0)-hept-2-en-derivater,fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
FR2708928A1 (fr) Procédé de préparation de 2-halogéno-éthyl-malonates de dialkyle.
AR002583A1 (es) Preparado gel oftalmico esteril goteable y procedimiento para su elaboracion

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 424043

Country of ref document: ES